Drug resistant malaria spreads in South East Asia

pharmafile | July 23, 2019 | News story | Manufacturing and Production South East Asia, global health, infectious diseases, malaria, parasites 

Drug resistant malaria parasites are spreading rapidly in South East Asia, according to researchers from Thailand and the United Kingdom.

The drug resistant parasites have spread from Cambodia into Thailand, Laos and Vietnam, according to a study published in the journal The Lancet Infectious Diseases.

Between 2008 and 2013, a multidrug resistant strain of malaria spread across Cambodia causing high rates of treatment failure with the frontline combination therapy dihydroartemisinin-piperaquine.

By 2016-2017 the researchers found the parasite had become highly prevalent in both north eastern Thailand and Vietnam. The parasite was also found in Laos. Before 2009 the drug resistant strain of malaria was only found in western Cambodia.

The emergence of drug resitant strains of malaria puts global malaria targets at risk. However, while the drug resistant parasite had become prevalent in South East Asia, its resistance to first line therapies does not mean it’s entirely untreatable.

“With the spread and intensification of resistance, our findings highlight the urgent need to adopt alternative first-line treatments”, Professor Tran Tinh Hien, from the Oxford University Clinical Research Unit, in Vietnam, said to the BBC.

The findings come as incidence of both malaria and malaria mortality has increased since 2015. While significant progress has been made, drug resistant malaria parasites threaten this progress. Researchers are concerned the drug resistant parasite could spread to Africa.

“This highly successful resistant parasite strain is capable of invading new territories and acquiring new genetic properties, raising the terrifying prospect that it could spread to Africa, where most malaria cases occur, as resistance to chloroquine did in the 1980s, contributing to millions of deaths,” Professor Olivo Miotto, from the Wellcome Sanger Institute and University of Oxford, said.

Louis Goss

Related Content


The Autumn 2020 edition of Pharmafile is available to read for free online now!

The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 …


FDA grants marketing approval for US Army’s malaria treatment

The FDA has granted marketing approval for the US Army Medical Research and Development Command’s …

Malaria treatment in Angola

Scientists in Kenya discover microbe that could stop transmission of malaria

Researchers studying malaria in Kenya have discovered a microbe that blocks transmission of malaria from …

Latest content